Company intelligence / Profile preview
Ardelyx
Waltham, Massachusetts, United Statesardelyx.com ↗
- Ownership
- Public · ARDX
- Employees
- ~150
- Development stage
- Other
01
Overview
Ardelyx has successfully commercialized two first-in-class medicines in the United States—IBSRELA® for IBS-C and XPHOZAH® for hyperphosphatemia in chronic kidney disease patients on dialysis. The company continues to advance its pipeline with ongoing Phase 3 trials for pediatric IBS-C and early-stage candidates targeting gastrointestinal diseases. International expansion includes a licensing partnership in China where tenapanor’s NDA was accepted for review by the NMPA
- Therapeutic areas
- GastroenterologyNephrology
- Modalities
- Small molecules (notably NHE3 inhibitors)
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
03
Partnerships
Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. (“Fosun Pharma”) – exclusive rights to market/sell tenapanor in China/Hong Kong/Macau; milestone payments/licensing dealOther partnerships not specifically detailed.
04
Financials
- Market cap
- $745.1M
- Total revenue
- $407.3M
- Enterprise value
- $716.1M
Beyond the preview
Go deeper on Ardelyx.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ardelyx.